A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 12, 2000, Pages 1625-1629

  Canducci, F ^a   Armuzzi, A ^a   Cremonini, F ^a   Cammarota, G ^a   Bartolozzi, F ^a   Pola, P ^a   Gasbarrini, G ^a   Gasbarrini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; RABEPRAZOLE;

ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CELL VIABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; EPITHELIUM CELL; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ACID SECRETION; STOMACH EPITHELIUM;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AMOXICILLIN; BENZIMIDAZOLES; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER PYLORI; HUMANS; LACTOBACILLUS ACIDOPHILUS; MALE; MIDDLE AGED; OMEPRAZOLE; PATIENT COMPLIANCE; PROSPECTIVE STUDIES;

EID: 0034536409     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00885.x     Document Type: Article

References (25)

1. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
2. Current regimens for treatment of Helicobacter pylori infection
3. Eradication of Helicobacter pylori: An objective assessment of current therapies
4. Efficacy of a multistep strategy for Helicobacter pylori eradication
5. Five-days regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxicillin or tinidazole for Helicobacter pylori infection
6. Eradication of Helicobacter pylori: Why does it fail?
7. Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora
8. Comparative effects of omeprazole, amoxycillin, plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients
9. The relationship of enteric bacteric population to gastrointestinal function and disease
10. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells
11. Rewiev article: The use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease
12. Bacteriocines of gram-positive bacteria
13. Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat killed Lactobacillus
14. Effect of erithromycin and an extract of heat-killed Lactobacillus acidophilus on intestinal colonization and traslocation of Campylobacter jejuni in the axenic mouse
15. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model
16. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus Strain LB
17. Effect of Whey-based Culture Supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans
18. Management of acute diarrhoea in infants and young children: Controlled study of the antidiarrhoeal efficacy of killed L. acidophilus (LB Strain) versus a placebo and a reference drug (loperamide)
19. Treatment of Irritable Bowel Syndrome with Lacteol Fort: A randomized double-blind, cross-over trial
20. Review article: Urea breath tests for detecting Helicobacter pylori
21. Proposal for use of a standard side effect scoring system in studies exploring treatment regimens
22. Potential of using lactic acid bacteria for therapy and immunomodulation in man
23. Immunomodulating effects of lactic acid bacteria on mucosal and tumoral immunity
24. Heat-killed Lactobacillus acidophilus inhibits adhesion of Escherichia coli B41 to Hela cells
25. Controlled clinical trial of Lacteol Fort compared with a placebo and reference drug in the treatment of acute diarrhea in the adult